One of the most common uses for peripheral liquid embolic in the treatment of brain aneurysms. These are weakened areas in the wall of a blood vessel that can balloon outwards, putting pressure on surrounding structures and potentially leading to a dangerous rupture. Liquid embolics can be introduced into the aneurysm through a minimally invasive procedure, where they will solidify and effectively seal off the vessel, reducing the risk of a rupture. Another common indication for liquid embolic systems is in the treatment of arteriovenous malformations (AVMs).

LavaTM peripheral liquid embolic has excellent diffusibility and flowability and visibility. It refers to the ability of a liquid embolic agent to diffuse into small blood vessels and occlude them. The liquid carrier used in diffusible agents is designed to be low viscosity and to flow easily. This ensures that the embolic agent can reach all desired areas of the target vessel and occlude them. Flowability refers to the ability of a liquid embolic agent to flow easily through vessels during administration. LavaTM peripheral liquid embolic agents are made up of a high viscosity polymer that is suspended in a low viscosity carrier. The high viscosity of the polymer ensures that the embolic agent will not dislodge or migrate once it has been deposited in the target vessel. The low viscosity of the carrier ensures that the embolic agent will flow easily through small and tortuous vessels, allowing for precise intraoperative control.